These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17675817)

  • 1. [Inflammatory bowel disease: current progress and future aspect].
    Ogata H; Hibi T
    Nihon Shokakibyo Gakkai Zasshi; 2007 Aug; 104(8):1155-64. PubMed ID: 17675817
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
    Ghosh N; Chaki R; Mandal V; Lin GD; Mandal SC
    Int Rev Immunol; 2010; 29(1):4-37. PubMed ID: 20100080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic jigsaw of inflammatory bowel disease.
    Watts DA; Satsangi J
    Gut; 2002 May; 50 Suppl 3(Suppl 3):III31-6. PubMed ID: 11953330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New therapies for inflammatory bowel disease].
    Matsui T
    Nihon Shokakibyo Gakkai Zasshi; 2005 Jul; 102(7):855-65. PubMed ID: 16038431
    [No Abstract]   [Full Text] [Related]  

  • 5. Inflammatory bowel disease in pregnancy.
    Korelitz BI
    Gastroenterol Clin North Am; 1992 Dec; 21(4):827-34. PubMed ID: 1478738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adhesion molecules: their role in physiopathology and treatment of inflammatory bowel disease].
    Panés J
    Gastroenterol Hepatol; 1999 Dec; 22(10):514-24. PubMed ID: 10650667
    [No Abstract]   [Full Text] [Related]  

  • 7. Inflammatory bowel disease: short- and long-term treatments.
    Bickston SJ; Cominelli F
    Dis Mon; 1998 Apr; 44(4):144-72. PubMed ID: 9580743
    [No Abstract]   [Full Text] [Related]  

  • 8. Inflammatory bowel disease approaching the 3rd millennium: pathogenesis and therapeutic implications?
    Ardizzone S; Bollani S; Manzionna G; Bianchi Porro G
    Eur J Gastroenterol Hepatol; 1999 Jan; 11(1):27-32. PubMed ID: 10495168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in inflammatory bowel disease.
    Su C; Lichtenstein GR
    Med Clin North Am; 2002 Nov; 86(6):1497-523. PubMed ID: 12510462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.
    Silverberg MS; Satsangi J; Ahmad T; Arnott ID; Bernstein CN; Brant SR; Caprilli R; Colombel JF; Gasche C; Geboes K; Jewell DP; Karban A; Loftus EV; Peña AS; Riddell RH; Sachar DB; Schreiber S; Steinhart AH; Targan SR; Vermeire S; Warren BF
    Can J Gastroenterol; 2005 Sep; 19 Suppl A():5A-36A. PubMed ID: 16151544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory bowel disease: an update on the fundamental biology and clinical management.
    Blumberg R; Cho J; Lewis J; Wu G
    Gastroenterology; 2011 May; 140(6):1701-3. PubMed ID: 21530735
    [No Abstract]   [Full Text] [Related]  

  • 12. Extended abstract: Tacrolimus and cyclosporine in inflammatory bowel disease.
    Stange EF
    Dig Dis; 2012; 30 Suppl 3():119-20. PubMed ID: 23295702
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammatory bowel disease: short- and long-term treatments.
    Bickston SJ; Cominelli F
    Adv Intern Med; 1998; 43():143-74. PubMed ID: 9506181
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of inflammatory bowel disease: past, present and future.
    Keyashian K; Annunziata ML; Sakuraba A; Hanauer S
    Expert Rev Clin Immunol; 2012 May; 8(4):303-5. PubMed ID: 22607175
    [No Abstract]   [Full Text] [Related]  

  • 15. The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.
    Sofia MA; Rubin DT
    Dig Dis Sci; 2017 Apr; 62(4):833-842. PubMed ID: 28197743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the immunopathology of chronic inflammatory bowel disease.
    Ehrhardt RO
    Semin Gastrointest Dis; 1996 Jul; 7(3):144-50. PubMed ID: 8817766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping.
    Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of translational research in inflammatory bowel disease].
    Abreu MT; Sparrow MP
    Rev Gastroenterol Mex; 2007; 72(2):146-53. PubMed ID: 17966376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in patients with ulcerative colitis (UC): influence of disease activity and familial study.
    Reumaux D; Colombel JF; Delecourt L; Noël LH; Cortot A; Duthilleul P
    Adv Exp Med Biol; 1993; 336():515-8. PubMed ID: 8296667
    [No Abstract]   [Full Text] [Related]  

  • 20. Biologic therapies in inflammatory bowel disease.
    Cohen LB; Nanau RM; Delzor F; Neuman MG
    Transl Res; 2014 Jun; 163(6):533-56. PubMed ID: 24467968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.